Join CIDRAP-ASP for a webinar discussing the importance of surveillance for qualifying and quantifying antimicrobial resistance (AMR), and learn about the challenges of conducting surveillance in low and middle-income settings. We will also discuss how improving utilization of current diagnostic and surveillance methods can inform local, regional, and global policy, and how new technologies will enable improved adoption and tracking.
Our expert presenters are:
- Elvira Garza González, PhD, Faculty of Medicine, Autonomous University of Nuevo León
- Carlos Arturo Álvarez Moreno, MD, PhD, Infectious Diseases Specialist, National University of Colombia
Time for Q&A will follow the presentation. Continuing education credit for physicians and pharmacists (ACCME and ACPE) provided.
Date and Time
May 4, 6:00 - 7:15pm CDT
This program has been designed to meet the educational needs of physicians and pharmacists.
At the completion of this activity, the participant will be able to:
Describe the current diagnostic and surveillance tools available in resource-limited settings
Use surveillance data to connect with policy actions
Explain the importance of improving laboratory capacity and diagnostic testing for the collection and reporting of AMR surveillance data
This activity is jointly provided by ProCE, LLC, and CIDRAP (Center for Infectious Disease Research and Policy). ProCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-22-155-L01-P has been assigned to this live knowledge-based activity (initial release date 5-4-2022). This CE activity is approved for 1.25 contact hours (0.125 CEU) in states that recognize ACPE providers. This CE activity is provided at no cost to participants. Successful completion of the online post-test and evaluation at www.ProCE.com is required to receive CE credit. CE credit will be uploaded to NABP/CPE Monitor. No partial credit will be given.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Clinical Care Options, LLC (CCO), ProCE, LLC, and CIDRAP. Clinical Care Options, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
CCO designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
ProCE, LLC requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to ProCE policy. ProCE is committed to providing its learners with high-quality CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company. Faculty disclosures will be provided prior to the start of the CE activity.
This activity is supported by an educational grant from BD (Becton, Dickinson, and Company).